Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
2'-F-RNA
Interleukin-17A/F
Protein
35.8 nM (reported value)
Binding buffer-145mM sodium chloride, 5.4 mM potassium chloride, 0.8 mM magnesium chloride, 1.8 mM calcium chloride, 20 mM Tris-HCl (pH 7.6) supplemented with 0.05% Tween20
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
See also APTAF42.
Interleukin 17A/F (IL-17A/F) (AptAF42dope1) (ID# 323)
5'rGprGprGp fCpfUprAp rGpfCpfUp rGprApfUp fCprGpfUp rApfCpfCp rAprGpfUp rAprGpfCp rGpfUprGp rGpfCpfCp fUprGprGp rGprGprGp rGpfCpfCp fUprAprGp fUpfCprGp fUprGpfCp rGprApfUp rApfCpfUp rAprApfCp rAprGpfCp fUprAprAp fCprApfCp fCpfCp3'
75
21984.1 g/mole
657400 L/(mole·cm)
60.29%
1.52
33.44
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Adachi, H et al. (2011). Antagonistic rna aptamer specific to a heterodimeric form of human interleukin-17a/f. Biochimie, 93(2011), 1081-1088. doi: 10.1016/j.biochi.2011.04.003
Have your aptamer oligo synthesized ORDER NOW
We are always looking for ways to improve. Please tell us what you think.